Skip to main content
PMC home page
Tobacco Control logoLink to Tobacco Control
. 1998 Sep;7(3):281–293. doi: 10.1136/tc.7.3.281

Reducing the addictiveness of cigarettes

J Henningfield, N Benowitz, J Slade, T Houston, R Davis, S Deitchman
PMCID: PMC1763900  PMID: 9825424

Abstract

OBJECTIVE—To assess the feasibility of reducing tobacco-caused disease by gradually removing nicotine from cigarettes until they would not be effective causes of nicotine addiction.
DATA SOURCES—Issues posed by such an approach, and potential solutions, were identified from analysis of literature published by the US Food and Drug Administration (FDA) in its 1996 Tobacco Rule, comments of the tobacco industry and other institutions and individuals on the rule, review of the reference lists of relevant journal articles, other government publications, and presentations made at scientific conferences.
DATA SYNTHESIS—The role of nicotine in causing and sustaining tobacco use was evaluated to project the impact of a nicotine reduction strategy on initiation and maintenance of, and relapse to, tobacco use. A range of potential concerns and barriers was addressed, including the technical feasibility of reducing cigarette nicotine content to non-addictive levels, the possibility that compensatory smoking would reduce potential health benefits, and whether such an approach would foster illicit ("black market") tobacco sales. Education, treatment, and research needs to enable a nicotine reduction strategy were also addressed. The Council on Scientific Affairs came to the following conclusions: (a) gradually eliminating nicotine from cigarettes is technically feasible; (b) a nicotine reduction strategy holds great promise in preventing adolescent tobacco addiction and assisting the millions of current cigarette smokers in their efforts to quit using tobacco products; (c) potential problems such as compensatory over-smoking of denicotinised cigarettes and black market sales could be minimised by providing alternate forms of nicotine delivery with less or little risk to health, as part of expanded access to treatment; and (d) such a strategy would need to be accompanied by relevant research and increased efforts to educate consumers and health professionals about tobacco and health.
CONCLUSIONS—The council recommends the following: (a) that cessation of tobacco use should be the goal for all tobacco users; (b) that the American Medical Association continue to support FDA authority over tobacco products, and FDA classification of nicotine as a drug and tobacco products as drug-delivery devices; (c) that research be encouraged on cigarette modifications that may result in less addicting cigarettes; (d) that the FDA require that the addictiveness of cigarettes be reduced within 5-10 years; (e) expanded surveillance to monitor trends in the use of tobacco products and other nicotine-containing products; (f) expanded access to smoking cessation treatment, and strengthening of the treatment infrastructure; and (g) more accurate labelling of tobacco products, including a more meaningful and understandable indication of nicotine content.


Keywords: American Medical Association; addiction; nicotine; smoking cessation

Full Text

The Full Text of this article is available as a PDF (160.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahluwalia J. S. Reaching the medically underserved with the AHCPR guideline. Tob Control. 1997;6 (Suppl 1):S29–S32. [PubMed] [Google Scholar]
  2. Baron J. A. Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spurious. Br Med Bull. 1996 Jan;52(1):58–73. doi: 10.1093/oxfordjournals.bmb.a011533. [DOI] [PubMed] [Google Scholar]
  3. Benowitz N. L., Fitzgerald G. A., Wilson M., Zhang Q. Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol. 1993 Oct;22(4):1159–1167. doi: 10.1016/0735-1097(93)90431-y. [DOI] [PubMed] [Google Scholar]
  4. Benowitz N. L., Henningfield J. E. Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N Engl J Med. 1994 Jul 14;331(2):123–125. doi: 10.1056/NEJM199407143310212. [DOI] [PubMed] [Google Scholar]
  5. Benowitz N. L., Jacob P., 3rd, Yu L., Talcott R., Hall S., Jones R. T. Reduced tar, nicotine, and carbon monoxide exposure while smoking ultralow- but not low-yield cigarettes. JAMA. 1986 Jul 11;256(2):241–246. [PubMed] [Google Scholar]
  6. Benowitz N. L., Kuyt F., Jacob P., 3rd Circadian blood nicotine concentrations during cigarette smoking. Clin Pharmacol Ther. 1982 Dec;32(6):758–764. doi: 10.1038/clpt.1982.233. [DOI] [PubMed] [Google Scholar]
  7. Benowitz N. L. Pharmacology of nicotine: addiction and therapeutics. Annu Rev Pharmacol Toxicol. 1996;36:597–613. doi: 10.1146/annurev.pa.36.040196.003121. [DOI] [PubMed] [Google Scholar]
  8. Bickel W. K., Hughes J. R., DeGrandpre R. J., Higgins S. T., Rizzuto P. Behavioral economics of drug self-administration. IV. The effects of response requirement on the consumption of and interaction between concurrently available coffee and cigarettes. Psychopharmacology (Berl) 1992;107(2-3):211–216. doi: 10.1007/BF02245139. [DOI] [PubMed] [Google Scholar]
  9. Blum A. Regulation of the nicotine content of cigarettes. N Engl J Med. 1994 Dec 1;331(22):1531–1532. [PubMed] [Google Scholar]
  10. Burns D., Benowitz N., N'Connolly G. N., Cummings K. M., Davis R. M., Henningfield J. E., Shopland D. R., Warner K. E. What should be the elements of any settlement with the tobacco industry? Tob Control. 1997 Spring;6(1):1–4. [PMC free article] [PubMed] [Google Scholar]
  11. Butschky M. F., Bailey D., Henningfield J. E., Pickworth W. B. Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers. Pharmacol Biochem Behav. 1995 Jan;50(1):91–96. doi: 10.1016/0091-3057(94)00269-o. [DOI] [PubMed] [Google Scholar]
  12. Chaloupka F. J., Wechsler H. Price, tobacco control policies and smoking among young adults. J Health Econ. 1997 Jun;16(3):359–373. doi: 10.1016/s0167-6296(96)00530-9. [DOI] [PubMed] [Google Scholar]
  13. Cohen S., Lichtenstein E., Prochaska J. O., Rossi J. S., Gritz E. R., Carr C. R., Orleans C. T., Schoenbach V. J., Biener L., Abrams D. Debunking myths about self-quitting. Evidence from 10 prospective studies of persons who attempt to quit smoking by themselves. Am Psychol. 1989 Nov;44(11):1355–1365. doi: 10.1037//0003-066x.44.11.1355. [DOI] [PubMed] [Google Scholar]
  14. Covey L. S., Glassman A. H., Stetner F. Major depression following smoking cessation. Am J Psychiatry. 1997 Feb;154(2):263–265. doi: 10.1176/ajp.154.2.263. [DOI] [PubMed] [Google Scholar]
  15. Djordjevic M. V., Brunnemann K. D., Hoffmann D. The need for regulation of carcinogenic N-nitrosamines in oral snuff. Food Chem Toxicol. 1993 Jul;31(7):497–501. doi: 10.1016/0278-6915(93)90109-c. [DOI] [PubMed] [Google Scholar]
  16. Djordjevic M. V., Fan J., Ferguson S., Hoffmann D. Self-regulation of smoking intensity. Smoke yields of the low-nicotine, low-'tar' cigarettes. Carcinogenesis. 1995 Sep;16(9):2015–2021. doi: 10.1093/carcin/16.9.2015. [DOI] [PubMed] [Google Scholar]
  17. Djordjevic M. V., Hoffmann D., Hoffmann I. Nicotine regulates smoking patterns. Prev Med. 1997 Jul-Aug;26(4):435–440. doi: 10.1006/pmed.1997.0184. [DOI] [PubMed] [Google Scholar]
  18. Fiore M. C., Novotny T. E., Pierce J. P., Giovino G. A., Hatziandreu E. J., Newcomb P. A., Surawicz T. S., Davis R. M. Methods used to quit smoking in the United States. Do cessation programs help? JAMA. 1990 May 23;263(20):2760–2765. [PubMed] [Google Scholar]
  19. Gilpin E. A., Pierce J. P. Trends in adolescent smoking initiation in the United States: is tobacco marketing an influence? Tob Control. 1997 Summer;6(2):122–127. doi: 10.1136/tc.6.2.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Giovino G. A., Henningfield J. E., Tomar S. L., Escobedo L. G., Slade J. Epidemiology of tobacco use and dependence. Epidemiol Rev. 1995;17(1):48–65. doi: 10.1093/oxfordjournals.epirev.a036185. [DOI] [PubMed] [Google Scholar]
  21. Glassman A. H., Helzer J. E., Covey L. S., Cottler L. B., Stetner F., Tipp J. E., Johnson J. Smoking, smoking cessation, and major depression. JAMA. 1990 Sep 26;264(12):1546–1549. [PubMed] [Google Scholar]
  22. Goldberg S. R., Henningfield J. E. Reinforcing effects of nicotine in humans and experimental animals responding under intermittent schedules of i.v. drug injection. Pharmacol Biochem Behav. 1988 May;30(1):227–234. doi: 10.1016/0091-3057(88)90450-9. [DOI] [PubMed] [Google Scholar]
  23. Henningfield J. E., Jasinski D. R. Pharmacologic basis for nicotine replacement. Prog Clin Biol Res. 1988;261:35–61. [PubMed] [Google Scholar]
  24. Henningfield J. E., Keenan R. M. Nicotine delivery kinetics and abuse liability. J Consult Clin Psychol. 1993 Oct;61(5):743–750. doi: 10.1037//0022-006x.61.5.743. [DOI] [PubMed] [Google Scholar]
  25. Henningfield J. E., Kozlowski L. T., Benowitz N. L. A proposal to develop meaningful labeling for cigarettes. JAMA. 1994 Jul 27;272(4):312–314. [PubMed] [Google Scholar]
  26. Henningfield J. E. Nicotine medications for smoking cessation. N Engl J Med. 1995 Nov 2;333(18):1196–1203. doi: 10.1056/NEJM199511023331807. [DOI] [PubMed] [Google Scholar]
  27. Henningfield J. E. Pharmacologic basis and treatment of cigarette smoking. J Clin Psychiatry. 1984 Dec;45(12 Pt 2):24–34. [PubMed] [Google Scholar]
  28. Henningfield J. E., Slade J. Tobacco-dependence medications: public health and regulatory issues. Food Drug Law J. 1998;53 Suppl:75–114. [PubMed] [Google Scholar]
  29. Hoffmann D., Djordjevic M. V., Hoffmann I. The changing cigarette. Prev Med. 1997 Jul-Aug;26(4):427–434. doi: 10.1006/pmed.1997.0183. [DOI] [PubMed] [Google Scholar]
  30. Hoffmann D., Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health. 1997 Mar;50(4):307–364. doi: 10.1080/009841097160393. [DOI] [PubMed] [Google Scholar]
  31. Hughes J. R. Dependence potential and abuse liability of nicotine replacement therapies. Biomed Pharmacother. 1989;43(1):11–17. doi: 10.1016/0753-3322(89)90185-6. [DOI] [PubMed] [Google Scholar]
  32. Hughes J. R., Gust S. W., Keenan R., Fenwick J. W., Skoog K., Higgins S. T. Long-term use of nicotine vs placebo gum. Arch Intern Med. 1991 Oct;151(10):1993–1998. [PubMed] [Google Scholar]
  33. Hughes J. R., Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry. 1986 Mar;43(3):289–294. doi: 10.1001/archpsyc.1986.01800030107013. [DOI] [PubMed] [Google Scholar]
  34. Hughes J. R. Regulation of the nicotine content of cigarettes. N Engl J Med. 1994 Dec 1;331(22):1530–1532. doi: 10.1056/NEJM199412013312221. [DOI] [PubMed] [Google Scholar]
  35. Hughes J. R. Treatment of smoking cessation in smokers with past alcohol/drug problems. J Subst Abuse Treat. 1993 Mar-Apr;10(2):181–187. doi: 10.1016/0740-5472(93)90043-2. [DOI] [PubMed] [Google Scholar]
  36. Humphrey H. H., 3rd Winning against big tobacco. Let's take the time to get it right. Public Health Rep. 1997 Sep-Oct;112(5):378–385. [PMC free article] [PubMed] [Google Scholar]
  37. Joossens L., Raw M. Cigarette smuggling in Europe: who really benefits? Tob Control. 1998 Spring;7(1):66–71. doi: 10.1136/tc.7.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Joossens L., Raw M. Smuggling and cross border shopping of tobacco in Europe. BMJ. 1995 May 27;310(6991):1393–1397. doi: 10.1136/bmj.310.6991.1393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Koop C. E., Kessler D. A. Final report of the Advisory Committee on Tobacco Policy and Public Health. Tob Control. 1997 Autumn;6(3):254–261. doi: 10.1136/tc.6.3.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Kozlowski L. T. Reduction of tobacco health hazards in continuing users: individual behavioral and public health approaches. J Subst Abuse. 1989;1(3):345–357. [PubMed] [Google Scholar]
  41. Lichtenstein E. Implications of the AHCPR guideline for psychological practice and research. Tob Control. 1997;6 (Suppl 1):S43–S46. [PubMed] [Google Scholar]
  42. McClure J. B., Skaar K., Tsoh J., Wetter D. W., Cinciripini P. M., Gritz E. R. Smoking cessation. 3: Needed healthcare policy changes. Behav Med. 1997 Spring;23(1):29–34. doi: 10.1080/08964289709596364. [DOI] [PubMed] [Google Scholar]
  43. McGovern P. G., Lando H. A. Reduced nicotine exposure and abstinence outcome in two nicotine fading methods. Addict Behav. 1991;16(1-2):11–20. doi: 10.1016/0306-4603(91)90035-g. [DOI] [PubMed] [Google Scholar]
  44. McLellan A. T., Childress A. R., Ehrman R., O'Brien C. P., Pashko S. Extinguishing conditioned responses during opiate dependence treatment turning laboratory findings into clinical procedures. J Subst Abuse Treat. 1986;3(1):33–40. doi: 10.1016/0740-5472(86)90006-1. [DOI] [PubMed] [Google Scholar]
  45. Meisch R. A., Thompson T. Ethanol as a reinforcer: effects of fixed-ratio size and food deprivation. Psychopharmacologia. 1973 Jan 1;28(2):171–183. doi: 10.1007/BF00421402. [DOI] [PubMed] [Google Scholar]
  46. Newhouse P. A., Hughes J. R. The role of nicotine and nicotinic mechanisms in neuropsychiatric disease. Br J Addict. 1991 May;86(5):521–526. doi: 10.1111/j.1360-0443.1991.tb01801.x. [DOI] [PubMed] [Google Scholar]
  47. Ockene J. K., Zapka J. Changing provider behaviour: provider education and training. Tob Control. 1997;6 (Suppl 1):S63–S67. [PubMed] [Google Scholar]
  48. Oncken C. A., Hardardottir H., Hatsukami D. K., Lupo V. R., Rodis J. F., Smeltzer J. S. Effects of transdermal nicotine or smoking on nicotine concentrations and maternal-fetal hemodynamics. Obstet Gynecol. 1997 Oct;90(4 Pt 1):569–574. doi: 10.1016/s0029-7844(97)00309-8. [DOI] [PubMed] [Google Scholar]
  49. Oncken C. A., Hatsukami D. K., Lupo V. R., Lando H. A., Gibeau L. M., Hansen R. J. Effects of short-term use of nicotine gum in pregnant smokers. Clin Pharmacol Ther. 1996 Jun;59(6):654–661. doi: 10.1016/S0009-9236(96)90005-3. [DOI] [PubMed] [Google Scholar]
  50. Page J. A. Federal regulation of tobacco products and products that treat tobacco dependence: are the playing fields level? Food Drug Law J. 1998;53 Suppl:11–42. [PubMed] [Google Scholar]
  51. Perkins K. A., DiMarco A., Grobe J. E., Scierka A., Stiller R. L. Nicotine discrimination in male and female smokers. Psychopharmacology (Berl) 1994 Dec;116(4):407–413. doi: 10.1007/BF02247470. [DOI] [PubMed] [Google Scholar]
  52. Perkins K. A., Grobe J. E., Caggiula A., Wilson A. S., Stiller R. L. Acute reinforcing effects of low-dose nicotine nasal spray in humans. Pharmacol Biochem Behav. 1997 Feb;56(2):235–241. doi: 10.1016/s0091-3057(96)00216-x. [DOI] [PubMed] [Google Scholar]
  53. Pierce J. P., Gilpin E. How long will today's new adolescent smoker be addicted to cigarettes? Am J Public Health. 1996 Feb;86(2):253–256. doi: 10.2105/ajph.86.2.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Pinney J. M. AHCPR smoking cessation guideline: its' goals and impact. Tob Control. 1997;6 (Suppl 1):S1–S1. doi: 10.1136/tc.6.suppl_1.s1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Pritchard W. S., Robinson J. H., Guy T. D., Davis R. A., Stiles M. F. Assessing the sensory role of nicotine in cigarette smoking. Psychopharmacology (Berl) 1996 Sep;127(1):55–62. doi: 10.1007/BF02805975. [DOI] [PubMed] [Google Scholar]
  56. Robinson J. H., Pritchard W. S., Davis R. A. Psychopharmacological effects of smoking a cigarette with typical "tar" and carbon monoxide yields but minimal nicotine. Psychopharmacology (Berl) 1992;108(4):466–472. doi: 10.1007/BF02247423. [DOI] [PubMed] [Google Scholar]
  57. Rose J. E., Levin E. D. Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking. Br J Addict. 1991 May;86(5):605–609. doi: 10.1111/j.1360-0443.1991.tb01816.x. [DOI] [PubMed] [Google Scholar]
  58. Russell M. A. Low-tar medium-nicotine cigarettes: a new approach to safer smoking. Br Med J. 1976 Jun 12;1(6023):1430–1433. doi: 10.1136/bmj.1.6023.1430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Russell M. A., Sutton S. R., Iyer R., Feyerabend C., Vesey C. J. Long-term switching to low-tar low-nicotine cigarettes. Br J Addict. 1982 Jun;77(2):145–158. doi: 10.1111/j.1360-0443.1982.tb01416.x. [DOI] [PubMed] [Google Scholar]
  60. Shiffman S., Gitchell J., Pinney J. M., Burton S. L., Kemper K. E., Lara E. A. Public health benefit of over-the-counter nicotine medications. Tob Control. 1997 Winter;6(4):306–310. doi: 10.1136/tc.6.4.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Shiffman S., Paty J. A., Gnys M., Kassel J. D., Elash C. Nicotine withdrawal in chippers and regular smokers: subjective and cognitive effects. Health Psychol. 1995 Jul;14(4):301–309. doi: 10.1037//0278-6133.14.4.301. [DOI] [PubMed] [Google Scholar]
  62. Slade J., Bero L. A., Hanauer P., Barnes D. E., Glantz S. A. Nicotine and addiction. The Brown and Williamson documents. JAMA. 1995 Jul 19;274(3):225–233. [PubMed] [Google Scholar]
  63. Slade J., Henningfield J. E. Tobacco product regulation: context and issues. Food Drug Law J. 1998;53 Suppl:43–74. [PubMed] [Google Scholar]
  64. Thun M. J., Day-Lally C. A., Calle E. E., Flanders W. D., Heath C. W., Jr Excess mortality among cigarette smokers: changes in a 20-year interval. Am J Public Health. 1995 Sep;85(9):1223–1230. doi: 10.2105/ajph.85.9.1223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Thun M. J., Lally C. A., Flannery J. T., Calle E. E., Flanders W. D., Heath C. W., Jr Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst. 1997 Nov 5;89(21):1580–1586. doi: 10.1093/jnci/89.21.1580. [DOI] [PubMed] [Google Scholar]
  66. Valentine J. D., Hokanson J. S., Matta S. G., Sharp B. M. Self-administration in rats allowed unlimited access to nicotine. Psychopharmacology (Berl) 1997 Oct;133(3):300–304. doi: 10.1007/s002130050405. [DOI] [PubMed] [Google Scholar]
  67. Wahlgren D. R., Hovell M. F., Slymen D. J., Conway T. L., Hofstetter C. R., Jones J. A. Predictors of tobacco use initiation in adolescents: a two-year prospective study and theoretical discussion. Tob Control. 1997 Summer;6(2):95–103. doi: 10.1136/tc.6.2.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Warner K. E., Peck C. C., Woosley R. L., Henningfield J. E., Slade J. Treatment of tobacco dependence: innovative regulatory approaches to reduce death and disease: preface. Food Drug Law J. 1998;53 Suppl:1–8. [PubMed] [Google Scholar]
  69. Warner K. E., Slade J., Sweanor D. T. The emerging market for long-term nicotine maintenance. JAMA. 1997 Oct 1;278(13):1087–1092. [PubMed] [Google Scholar]
  70. West R. J., Russell M. A. Cardiovascular and subjective effects of smoking before and after 24 h of abstinence from cigarettes. Psychopharmacology (Berl) 1987;92(1):118–121. doi: 10.1007/BF00215491. [DOI] [PubMed] [Google Scholar]

Articles from Tobacco Control are provided here courtesy of BMJ Publishing Group

RESOURCES